Tower Research Capital (TRC)’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$1K 7058
2021
Q4
$1K Buy
100
+74
+285% +$728 ﹤0.01% 6047
2021
Q3
$0 Sell
26
-491
-95% -$4.79K ﹤0.01% 6474
2021
Q2
$5K Buy
517
+417
+417% +$4.07K ﹤0.01% 4773
2021
Q1
$1K Buy
+100
New +$966 ﹤0.01% 5293

Other funds holding ISLE

Tower Research Capital (TRC)'s ISLE Position: Q1 2022 in Review

Tower Research Capital (TRC) sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q1 2022, closing a stake of 100 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in ISLE in Q1 2021 and held it in 4 quarters. The position peaked at $5K in Q2 2021. 69 funds tracked by Wall St. Rank hold ISLE as of Q1 2022.

  • Tower Research Capital (TRC) reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q1 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 100 Isleworth Healthcare Acquisition Corporation Common stock shares in Q1 2022, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 4 quarters.
  • Tower Research Capital (TRC)'s Isleworth Healthcare Acquisition Corporation Common stock position peaked at $5K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q1 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.